TB-D Thymosin β4

Suprepharmagroup Manufacturer & Supplier of TB-500 (Thymosin β4) CAS 77591-33-4 | GMP Peptide pro Laboratory Research

Suprepharma group Manufacturer & Supplier TB-500 (Thymosin β4), CAS No. 77591-33-4, praebet altam puritatem GMP-gradus peptide rudis materiae ad solas inquisitiones laboratorias. Cum professionalem peptidium rudis materiae supplementi inserviens Europa et America Septentrionali, severas qualitates signa, documenta COA, et catenas copia globali stabilis curet.

Quid est TB-D (Thymosin β4)?

Thymosin beta-4 (vulgo TB-500 appellata) est synthetica versio fragmenti peptidis naturaliter occurrentis e thymosin beta-4, a 43-amino acido interdum in mammalibus fibris late distributis.

TB-500 imprimis in investigationibus biochemicis et cellis migrationis adhibetur, textus regenerationis studiorum, inquisitiones angiogenesis-related, et experimenta modulationis cytoskeletalis.

Maximus Notitia:

Haec materia stricte suppeditatur ad solas investigationes laboratorias. Consumptio humana non destinatur, curatio clinica, usus veterinarii, vel amplificatio illegalis effectus.

Product Specifications - TB-500 (Thymosin β4)

• Item Specification
• Product Name TB-D / Thymosin β4
• CAS Number 77591-33-4
• Formulae hypotheticae C212H350N56O78S
• Molecular pondus ~ 4963.44 g/mol
• Aspectus White ad extemporalitatem album lyophilized pulveris
• Puritas ≥98% (HPLC)
• Solubilitas solubilis in aqua sterili vel solutiones buffered
• Repono -20°C, a luce custoditus
• Gradus Research Gradus / GMP-Compliant Productio Opera
• Documenta COA, MSDS praesto
• 
  

Characteres chemici & biologici

Longitudo peptide: amino acida 43

Munus structuralis: peptide actin-inding in cytoskeleton constitutione

Patus biologicum studuit:

• Cellula migrationis et differentiae
• Angiogenesis significat meatus
• TEXTUS interdum modeling
• Inflammatio responsio machinationes

TB-500 magna relatio facta est in biologia regenerativa et in exemplaribus investigationis cellularum mobilitatis.

Investigationis Applications (tantum Laboratorium usus)

In studiis academicis et preclinicis ambitibus TB-D inspicitur;

• Cellula multiplicatio et migratio pertentat
• Angiogenesis via studia
• TEXTUS reparatione modeling vitro
• Experimenta commercium cytoskeletalium
• Vulneris mechanismus investigationum sanationis

Selected Research Literature (Ad Academica Reference)

Studia thymosin beta-4 rum edita sunt in ephemeride pari recensita explorandi:

• Partes thymosin beta-4 in angiogenesis dispositione
• Cytoprotective actio in cordis TEXTUS exempla
• Modulationis inflammationis significatio meatus
• Actin polymerization machinationes

Investigatores referre possunt ad publicationes quae in PubMed et aliis databases scientificis sub "Thymosin beta-IV" sunt indicatae.

Quare elige Suprepharmagroup ut Tua TB-500 Manufacturer & Supplier?

1. GMP Compliant Vestibulum Opera

Productio facilities agunt sub regimine qualitatis systemata cum peptide signis pharmaceutical-gradus aligned.

2. Stabulum Rudis Material Supple Chain

Sustinemus longum tempus amino flumine acidum accedens societates, ad puritatem et batch reproducibilitatem constantem procurandam.

3. Internationalis Market Coverage

Nostra peptide rudimenta exportantur;

• Europa
• America Septentrionalis
• Southeast Asia
• Institutiones investigationis selectae per orbem

4. The Documenta Package

• Testimonium Analysis (COA)
• Materia Salutis Data Sheet (MSDS)
• Batch traceability
• HPLC puritatem tradit

Obsequium & Legal Statement

TB-D (Thymosin β4) unice praebetur ad investigationes laboratorias et studiorum scientiarum proposita.

Est:

• Non ut medicamento probatus
• Non pro homine vel veterinarii usu
• Non pro bodybuilding vel perficiendi amplificationem
• Non enim resale sicut operis pharmaceutical

Customers responsales sunt pro obsequio cum loci ordinationes praestandi.